All In MedTech

Device Trial Radar · NCT01608529

Feel Breathe, Restriction Device Ventilatory Nasal

Phase 1: Effects of a Restriction Device Ventilatory Nasal Flow on Pulmonary Ventilation and Gas Exchange During Exercise

Last checked: Nov 19, 2026Latest source record: May 17, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

27

Actual

Start

Jan 2011

Primary completion

Jul 2011

Study completion Dec 2011

Sponsor

Lead sponsor
University of CadizAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Consejo Superior de Deportes, Spain; European Regional Development Fund
First posted
May 31, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 25 years, up to 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

It has patented a restriction and filtering device ventilatory nasal flow FeelBreathe with the aim of increase nasal airflow resistance, therefore the objective was to examine the effects of FeelBreathe with lung ventilation and gas exchange during exercise.

Conditions

  • Mouth Breathing
  • Restrictive Breathing Pattern

Interventions

  • Feel Breathe, restriction device ventilatory nasalDevice

    The Feel Breathe (FB) consisted of a small adhesive strip that is placed across the bridge of the nose during exercise. The FB was place following procedures for placement as indicated by the manufacturer's directions, while the placebo nasal, was placed over the nostrils of the subject, without interfering nasal breathing; thus, nasal airflow resistance was not increase. Each subject was required to perform three identical submaximal exercises with intensity at 50% VT1-VT2 under different breathing conditions. The breathing conditions were: oronasal, nasal and FB breathing. All participants performed three trials of stable load (50% VT1-VT2) for 10 minutes in the three conditions mentioned above, setting the cadence at 70-75 rpm, and controlling the same in all three exercise conditions.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Impact of a restriction device ventilatory nasal over different physiological variables in cyclistsTime frame: Subjects were assessed during 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centro de Medicina del Deporte

    San Fernando, Cadiz, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.